Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
laser decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
laser decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
-
26881
Image_2_HvGBSSI mutation at the splicing receptor site affected RNA splicing and decreased amylose content in barley.JPEG
Published 2022“…The mutations in the Wx-1 decreased the enzymatic activity of the HvGBSSI enzyme and resulted in a decreased level in amylose content. …”
-
26882
Table_1_HvGBSSI mutation at the splicing receptor site affected RNA splicing and decreased amylose content in barley.DOCX
Published 2022“…The mutations in the Wx-1 decreased the enzymatic activity of the HvGBSSI enzyme and resulted in a decreased level in amylose content. …”
-
26883
Image_4_HvGBSSI mutation at the splicing receptor site affected RNA splicing and decreased amylose content in barley.JPEG
Published 2022“…The mutations in the Wx-1 decreased the enzymatic activity of the HvGBSSI enzyme and resulted in a decreased level in amylose content. …”
-
26884
-
26885
Knock-down of ERRα by shRNA (RNAi) decreases mRNA levels of multiple ERRα target genes.
Published 2009“…Knocking-down ERRα by shRNA (RNAi) led to significant decrease (*, P<0.05) in expression of ERRα target genes aromatase (<i>CYP19A1</i>), osteopontin (<i>SPP1</i>), and pS2 (<i>TFF1</i>) while ERα (<i>ESR1</i>) levels were not affected. …”
-
26886
-
26887
-
26888
-
26889
-
26890
-
26891
-
26892
Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation.
Published 2020“…Further, there is a structure-activity relationship between TPP side chain length and metabolic disruption; with inclusion of longer side chains resulting in the greatest decreases in mitochondria membrane potential and DHE oxidation.…”
-
26893
Identification of <i>T. gondii</i> Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion
Published 2014“…Finally, a knock-in parasite line expressing the C58S mutation showed decreased sensitivity to compound treatment in a quantitative 3D motility assay. …”
-
26894
-
26895
-
26896
Supplemental Figure 4: UAB30 decreased migration. from Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies
Published 2023“…Both cell lines showed a significant decrease in the ability to migrate following UAB30. …”
-
26897
Two Birds with One Stone: Spontaneous Size Separation and Growth Inhibition of Femtosecond Laser-Generated Surfactant-Free Metallic Nanoparticles via ex Situ SU‑8 Functionalization...
Published 2018“…Laser ablation in liquids (LAL) offers a facile technique to develop a large variety of surfactant-free nanomaterials with high purity. …”
-
26898
-
26899
Ursolic Acid Increases Skeletal Muscle and Brown Fat and Decreases Diet-Induced Obesity, Glucose Intolerance and Fatty Liver Disease
Published 2012“…Consistent with increased skeletal muscle and brown fat, ursolic acid increased energy expenditure, leading to reduced obesity, improved glucose tolerance and decreased hepatic steatosis. These data support a model in which ursolic acid reduces obesity, glucose intolerance and fatty liver disease by increasing skeletal muscle and brown fat, and suggest ursolic acid as a potential therapeutic approach for obesity and obesity-related illness.…”
-
26900